Michal Sarnecki
7PUBLICATIONS
30CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Feb 26, 2026
Immunogenicity and Safety of the ExPEC9V Escherichia coli Vaccine Co-Administered with a High-Dose Influenza Vaccine in Older Adults: A Placebo-Controlled, Randomized, Phase 3 Study.Isabel Leroux-Roels, Tracey A Day, Sofie Deleu
|Jun 14, 2024
A randomized phase 1/2a trial of ExPEC10V vaccine in adults with a history of UTI.Carlos A Fierro, Michal Sarnecki, Bart Spiessens
|May 23, 2024
Immunogenicity of 2 therapeutic mosaic HIV-1 vaccine strategies in individuals with HIV-1 on antiretroviral therapy.Boris Julg, Kathryn E Stephenson, Frank Tomaka
|Jan 18, 2024
Feasibility of tracking invasive Escherichia coli disease among older adults in a community setting: A prospective observational study.Joachim Doua, Miquel Ekkelenkamp, Theo Verheij
|Aug 23, 2023
Safety, Reactogenicity, Immunogenicity, and Dose Selection of 10-Valent Extraintestinal Pathogenic Escherichia coli Bioconjugate Vaccine (VAC52416) in Adults Aged 60-85 Years in a Randomized, Multicenter, Interventional, First-in-Human, Phase 1/2a Study.Carlos A Fierro, Michal Sarnecki, Joachim Doua
|Jun 26, 2022
Development and performance characteristics of novel code-based algorithms to identify invasive Escherichia coli disease.Stephen P Fortin, Luis Hernandez Pastor, Joachim Doua
Pageof 2
Frequent Collaborators
2 joint publications
Joachim Doua
2 joint publications
Jan Poolman
1 joint publications
Dohoon Kim
1 joint publications
Dominic Paquin-Proulx
1 joint publications
Michael A Eller
1 joint publications
Rasmi Thomas
1 joint publications
Nicolas Chomont
1 joint publications
Merlin L Robb
1 joint publications
Stephen P Fortin
1 joint publications
Joel Swerdel
